Vera Therapeutics Inc. (VERA)
VERA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$26.79
-3.35% on the day
Market cap
$1.9B
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | VERA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001831828 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-12-10 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-09-15 |
| Latest proxy | DEFA14A | 2026-04-09 |
Source: SEC EDGAR submissions feed, 474 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -11.6% |
| 1 month | -20.5% |
| 3 months | -31.6% |
| Year to date | -47.2% |
| 1 year | -12.2% |
| From 52-week high | -51.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SDGR | Schrodinger Inc. | $25.89 | -0.08% | $1.9B |
| LKFT | Lakefront Biotherapeutics | $29.05 | -1.76% | $1.9B |
| ADRX | ADARx Pharmaceuticals Inc. | $17.70 | -1.50% | $1.9B |
| URGN | UroGen Pharma Ltd. | $38.26 | -0.05% | $1.9B |
| XERS | Xeris Biopharma Holdings Inc. | $10.20 | -2.49% | $1.9B |
| MLYS | Mineralys Therapeutics Inc. | $21.00 | -5.53% | $1.9B |
| PVLA | Palvella Therapeutics Inc. | $128.51 | -4.37% | $1.9B |
| VRDN | Viridian Therapeutics Inc. | $18.22 | -0.44% | $2.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier